ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 73 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,000 | -25.0% | 33,918 | 0.0% | 0.00% | – |
| Q2 2022 | $8,000 | 0.0% | 33,918 | +12.4% | 0.00% | – |
| Q1 2022 | $8,000 | -52.9% | 30,168 | -3.2% | 0.00% | – |
| Q4 2021 | $17,000 | -46.9% | 31,168 | 0.0% | 0.00% | – |
| Q3 2021 | $32,000 | -22.0% | 31,168 | +3.3% | 0.00% | – |
| Q2 2021 | $41,000 | -19.6% | 30,168 | +1.7% | 0.00% | – |
| Q1 2021 | $51,000 | +920.0% | 29,663 | +531.1% | 0.00% | – |
| Q4 2020 | $5,000 | 0.0% | 4,700 | +18.4% | 0.00% | – |
| Q3 2020 | $5,000 | +25.0% | 3,970 | 0.0% | 0.00% | – |
| Q2 2020 | $4,000 | -63.6% | 3,970 | -58.9% | 0.00% | – |
| Q1 2020 | $11,000 | – | 9,651 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,528,120 | $38,210,000 | 1.53% |
| Cormorant Asset Management, LP | 850,000 | $2,593,000 | 0.41% |
| Palo Alto Investors LP | 1,656,644 | $5,053,000 | 0.24% |
| Granahan Investment Management | 1,745,604 | $5,324,000 | 0.16% |
| Spark Investment Management LLC | 318,500 | $980,000 | 0.13% |
| Opus Point Partners Management, LLC | 57,747 | $176,000 | 0.10% |
| SHEPHERD KAPLAN KROCHUK, LLC | 76,472 | $233,000 | 0.06% |
| Joel Isaacson & Co., LLC | 70,660 | $216,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $229,000 | 0.05% |
| Cornerstone Capital, Inc. | 59,200 | $181,000 | 0.04% |